Codexis (CDXS) Other Non Operating Income (2015 - 2026)
Codexis' (CDXS) quarterly Other Non Operating Income came in at -$1.3 million in Q1 2026, down 36.94% year-on-year from -$2.0 million in Q1 2025, and up 19.17% quarter-over-quarter from -$1.6 million in Q4 2025.
Codexis (CDXS) Other Non Operating Income (2015 - 2026) Analysis & Trends
Codexis' Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 36.94% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was -$5.2 million, a 52.3% increase from a year earlier, with the FY2025 full-year figure at -$4.8 million, up 53.69% from the prior year.
- Other Non Operating Income grew to -$1.3 million in Q1 2026 per CDXS's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $216000.0 in Q3 2022 and bottomed at -$8.3 million in Q4 2023.
- The 5-year median for Other Non Operating Income is -$984000.0 (2025), against an average of -$1.7 million.
- Across the five-year window, Other Non Operating Income jumped 96.59% in 2022 and slumped 31992.31% in 2023, its largest moves.
- Year by year, Other Non Operating Income stood at -$26000.0 in 2022, then slumped by 31992.31% to -$8.3 million in 2023, then jumped by 52.4% to -$4.0 million in 2024, then jumped by 59.82% to -$1.6 million in 2025, then gained by 19.17% to -$1.3 million in 2026.
- Per Business Quant, the three latest CDXS Other Non Operating Income figures stand at -$1.3 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -984,000.00 |
| Mar 31, 2025 | -942,000.00 |
| Dec 31, 2024 | -3.97 Mn |
| Sep 30, 2024 | -4.92 Mn |
| Jun 30, 2024 | -985,000.00 |
| Mar 31, 2024 | -516,000.00 |
| Dec 31, 2023 | -8.34 Mn |
| Sep 30, 2023 | -3.90 Mn |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 216,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 228,000.00 |
| Sep 30, 2021 | 983,000.00 |
| Jun 30, 2021 | 23,000.00 |